Cargando…

Clinical outcome and risk factors for recurrence in borderline ovarian tumours

We investigated the long-term prognosis of borderline ovarian tumours and determined risk factors for recurrence. One hundred and twenty-one borderline ovarian tumours treated between 1994 and 2003 at the participating institutions in the Tohoku Gynecologic Cancer Unit were retrospectively investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokoyama, Y, Moriya, T, Takano, T, Shoji, T, Takahashi, O, Nakahara, K, Yamada, H, Yaegashi, N, Okamura, K, Izutsu, T, Sugiyama, T, Tanaka, T, Kurachi, H, Sato, A, Tase, T, Mizunuma, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361313/ https://www.ncbi.nlm.nih.gov/pubmed/16685277 http://dx.doi.org/10.1038/sj.bjc.6603139

Ejemplares similares

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
por: Shoji, Tadahiro, et al.
Publicado: (2014)

Differential Expression of Progesterone Receptor Isoforms A and B in the Normal Ovary, and in Benign, Borderline, and Malignant Ovarian Tumors
por: Akahira, Jun‐ichi, et al.
Publicado: (2002)

Requirement for expert histopathological assessment of ovarian cancer and borderline tumours
por: Sengupta, P S, et al.
Publicado: (2000)

Fertility sparing treatment in borderline ovarian tumours
por: Alvarez, Rosa Maria, et al.
Publicado: (2015)

Fertility Sparing Surgery and Borderline Ovarian Tumours
por: Kasaven, Lorraine S., et al.
Publicado: (2022)

Identification of clinical and molecular features of recurrent serous borderline ovarian tumour
por: Lu, Ziyang, et al.
Publicado: (2022)

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor γ in epithelial ovarian tumours
por: Sakamoto, A, et al.
Publicado: (2004)

Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer
por: Akahira, J-i, et al.
Publicado: (2004)

Histopathology and indicators of borderline ovarian tumours with microinvasion in bitches
por: Makovicky, Peter, et al.
Publicado: (2023)

Immunohistochemical profiling of the tumour microenvironment in borderline and malignant ovarian tumours in young women
por: O'Neill, Danielle, et al.
Publicado: (2023)

Management of borderline ovarian tumours: a comprehensive review of the literature
por: Abascal-Saiz, Alejandra, et al.
Publicado: (2014)

The status of epidermal growth factor receptor in borderline ovarian tumours
por: Showeil, Rania, et al.
Publicado: (2016)

Borderline ovarian tumours: management in the era of fertility-sparing surgery
por: Maramai, Mattia, et al.
Publicado: (2020)

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study
por: Bjørge, T, et al.
Publicado: (2004)

Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
por: van Leeuwen, F.E., et al.
Publicado: (2011)

Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms
por: Levi, F, et al.
Publicado: (1999)

Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients
por: Yüksel, Dilek, et al.
Publicado: (2019)

A serous borderline ovarian tumour in a transgender male adolescent
por: Millington, Kate, et al.
Publicado: (2020)

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
por: Tuhkanen, Hanna, et al.
Publicado: (2009)

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study
por: Trillsch, F, et al.
Publicado: (2015)

Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours
por: Jia, Shuang-zheng, et al.
Publicado: (2018)

Four cases of endometrioid borderline ovarian tumour: case reports and literature review
por: Nakagawa, Eriko, et al.
Publicado: (2017)

Performance of the IOTA ADNEX Model on Selected Group of Patients with Borderline Ovarian Tumours
por: Gaurilcikas, Adrius, et al.
Publicado: (2020)

Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis
por: Bürger, Tobias, et al.
Publicado: (2015)

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
por: Takano, M, et al.
Publicado: (2006)

Expression of 5α‐Reductases in Human Epithelial Ovarian Cancer: Its Correlation with Androgen Receptor Status
por: Akahira, Jun‐Ichi, et al.
Publicado: (2001)

MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation
por: Nakai, Go, et al.
Publicado: (2018)

Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis
por: Hada, Taira, et al.
Publicado: (2021)

Genomic aberrations in borderline ovarian tumors
por: Micci, Francesca, et al.
Publicado: (2010)

Controversies in borderline ovarian tumors
por: Seong, Seok Ju, et al.
Publicado: (2015)

Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies
por: Akahira, J, et al.
Publicado: (2000)

Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors
por: Plett, Helmut, et al.
Publicado: (2020)

Clinicopathological aspects of patients with recurrence of borderline ovarian tumors
por: Oh, Sumin, et al.
Publicado: (2015)

Recurrence characteristics and clinicopathological results of borderline ovarian tumors
por: Niu, Lina, et al.
Publicado: (2021)

External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours
por: Bendifallah, S, et al.
Publicado: (2013)

Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer
por: Virant-Klun, Irma, et al.
Publicado: (2016)

A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
por: Shoji, Tadahiro, et al.
Publicado: (2017)

Malignant Ovarian Tumors with Induced Expression of Carbonyl Reductase Show Spontaneous Regression
por: Wang, Hui, et al.
Publicado: (2012)

Comment on ‘External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours'
por: Obermair, A
Publicado: (2014)

Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group
por: Ozenne, Adele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lbc43fqpn2i6geae11l3eck9iq